drugset
drugset / Trial / NCT07310407

Rutin and Vitamin C in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)

NCT07310407 ↗

Phase 2 Not yet recruiting 120 enrolled Ain Shams University
RandomizedParallel-groupOpen-labelTreatment

Summary

evaluate the combined effects of Rutin and Vitamin C versus Vitamin C alone on selected oxidative stress markers, inflammation, hepatic steatosis regression, and associated metabolic parameters in patients with MASLD

Timeline

Start
2026-01-01
Primary completion
2027-01-01
Completion
2027-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Rutin Unknown 60 mg Oral
Subject Vitamin C Other / unclassified 160 mg Oral
Subject Vitamin C Other / unclassified 500 mg Oral

Indications

metabolic dysfunction-associated steatotic liver disease